PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 622,000
+5,000 (0.80%)
Sep 4, 2025, 3:30 PM KST
PharmaResearch Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 126,993 | 92,043 | 76,551 | 40,577 | 46,689 | 32,774 | Upgrade |
Depreciation & Amortization | 15,068 | 13,645 | 11,996 | 10,602 | 9,552 | 8,360 | Upgrade |
Loss (Gain) From Sale of Assets | 191.66 | 11.92 | -36.11 | 5,846 | -229.6 | 362.6 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 3,120 | - | 839.66 | 1,246 | Upgrade |
Loss (Gain) From Sale of Investments | 3,508 | 20,191 | -3,042 | 2,259 | -943.49 | 261.14 | Upgrade |
Loss (Gain) on Equity Investments | -271.4 | -5,954 | -680.03 | 2,192 | -556.93 | -3,168 | Upgrade |
Stock-Based Compensation | 480.67 | 658.9 | 657.1 | 505.88 | - | - | Upgrade |
Provision & Write-off of Bad Debts | -195.83 | -244.35 | 582.21 | 290.45 | -406.73 | -1,309 | Upgrade |
Other Operating Activities | 21,371 | 17,385 | 6,512 | 7,598 | 1,932 | 4,037 | Upgrade |
Change in Accounts Receivable | -18,330 | -8,535 | 717.13 | -4,843 | -3,842 | -1,040 | Upgrade |
Change in Inventory | -11,927 | -11,940 | -28,188 | -8,374 | 2,927 | -8,247 | Upgrade |
Change in Accounts Payable | -1,189 | 7,724 | -559.07 | 597.78 | 397.75 | -3,622 | Upgrade |
Change in Unearned Revenue | 430.03 | 72.1 | 16.32 | 11.36 | - | - | Upgrade |
Change in Income Taxes | - | - | - | 9.63 | 1.52 | -2.43 | Upgrade |
Change in Other Net Operating Assets | 11,638 | 13,063 | -3,230 | 2,131 | 9,088 | 2,936 | Upgrade |
Operating Cash Flow | 147,767 | 138,122 | 64,945 | 59,404 | 65,297 | 32,392 | Upgrade |
Operating Cash Flow Growth | 41.70% | 112.67% | 9.33% | -9.03% | 101.59% | 68.07% | Upgrade |
Capital Expenditures | -34,550 | -36,415 | -12,063 | -17,257 | -20,645 | -34,785 | Upgrade |
Sale of Property, Plant & Equipment | 118.93 | 30.68 | 28.65 | 734.02 | - | 0.83 | Upgrade |
Cash Acquisitions | - | - | - | -35.01 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -4,363 | -2,310 | -623.05 | -460.83 | -2,786 | -597.98 | Upgrade |
Investment in Securities | -231,133 | -179,213 | -31,860 | 5,446 | -66,427 | -3,630 | Upgrade |
Other Investing Activities | 3,545 | 2,507 | -522.63 | -794.6 | -590.91 | 1,822 | Upgrade |
Investing Cash Flow | -276,213 | -225,538 | -44,668 | -11,908 | -93,755 | -36,209 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 15,000 | Upgrade |
Long-Term Debt Issued | - | 10,782 | - | - | 50,000 | 162.61 | Upgrade |
Total Debt Issued | 107.24 | 10,782 | - | - | 50,000 | 15,163 | Upgrade |
Short-Term Debt Repaid | - | - | - | -860 | -29.13 | - | Upgrade |
Long-Term Debt Repaid | - | -17,946 | -18,799 | -2,126 | -1,976 | -1,110 | Upgrade |
Total Debt Repaid | -18,251 | -17,946 | -18,799 | -2,986 | -2,005 | -1,110 | Upgrade |
Net Debt Issued (Repaid) | -18,144 | -7,164 | -18,799 | -2,986 | 47,995 | 14,053 | Upgrade |
Issuance of Common Stock | - | - | 359.24 | - | - | - | Upgrade |
Dividends Paid | -12,009 | -10,090 | -7,529 | -6,316 | -5,030 | -2,965 | Upgrade |
Other Financing Activities | -125.25 | -102.45 | -0 | - | -0 | - | Upgrade |
Financing Cash Flow | 169,722 | 182,643 | -25,969 | -9,301 | 42,965 | 11,088 | Upgrade |
Foreign Exchange Rate Adjustments | -2,318 | 1,118 | 4.41 | -76.12 | 300.33 | -293.87 | Upgrade |
Miscellaneous Cash Flow Adjustments | 1,758 | 1,758 | 0 | -6,862 | 151.51 | - | Upgrade |
Net Cash Flow | 40,715 | 98,103 | -5,687 | 31,257 | 14,959 | 6,977 | Upgrade |
Free Cash Flow | 113,217 | 101,707 | 52,883 | 42,147 | 44,652 | -2,393 | Upgrade |
Free Cash Flow Growth | 42.96% | 92.33% | 25.47% | -5.61% | - | - | Upgrade |
Free Cash Flow Margin | 25.17% | 29.05% | 20.26% | 21.64% | 28.98% | -2.20% | Upgrade |
Free Cash Flow Per Share | 10485.68 | 9879.60 | 5008.31 | 4224.85 | 4441.83 | -251.75 | Upgrade |
Cash Interest Paid | 2,360 | 428.67 | 493.61 | 159.45 | 196.15 | 116.99 | Upgrade |
Cash Income Tax Paid | 33,116 | 19,811 | 16,962 | 13,798 | 10,051 | 5,862 | Upgrade |
Levered Free Cash Flow | 67,495 | 67,225 | 21,153 | 25,115 | 27,225 | -18,756 | Upgrade |
Unlevered Free Cash Flow | 73,459 | 70,121 | 23,020 | 27,509 | 28,046 | -17,640 | Upgrade |
Change in Working Capital | -19,378 | 384.04 | -30,714 | -10,467 | 8,421 | -10,172 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.